TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED
OVERVIEW - TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED
Takeda Biopharmaceuticals India Private Limited is an unlisted private company incorporated on 15 April, 2015. It is classified as a private subsidiary of a foreign company and is located in Gurgaon, Haryana. It's authorized share capital is INR 265.01 cr and the total paid-up capital is INR 215.51 cr.
Takeda Biopharmaceuticals India's operating revenues range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 71.95 % over the previous year. At the same time, it's book networth has increased by 10.64 %. Other performance and liquidity ratios are available here.
Description: The company is engaged in providing bioequivalence, analytical research and custom synthesis and also providing end to end solution in clinical and analytical area for pharmaceuticals.
Products & Services: All drugs, medicines, medical equipments, herbal medicines etc.
Category: Service Provider
The current status of Takeda Biopharmaceuticals India Private Limited is - Active.
The last reported AGM (Annual General Meeting) of Takeda Biopharmaceuticals India Private Limited, per our records, was held on 01 December, 2023.
Takeda Biopharmaceuticals India Private Limited has four directors - Gopal Agrawal, Anoop Kishore Kamat, and others.
The Corporate Identification Number (CIN) of Takeda Biopharmaceuticals India Private Limited is U51909HR2015FTC055144. The registered office of Takeda Biopharmaceuticals India Private Limited is at 6th Floor, Tower C, Building No. 8, DLF Cyber City, DLF Phase II, Gurgaon, Gurgaon, Haryana.
REGISTERED DETAILS - TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED
CIN
U51909HR2015FTC055144
Incorporation Date / Age
15 April, 2015 / 9 yrs
Last Reported AGM Date
01 December, 2023
Authorized Capital
INR 26501.0 Lacs
Paidup Capital
INR 21551.3188 Lacs
industry*
Trading
type
Unlisted Private Company
category
Company limited by Shares
subcategory
Subsidiary of Foreign Company
Registered Address
6th Floor, Tower C, Building No. 8,
DLF Cyber City, DLF Phase II
Gurgaon
Gurgaon - 122001
Haryana - India
FINANCIAL HIGHLIGHTS - TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED
| Operating Revenue | Over INR 500 cr |
| EBITDA | 71.95 % |
| Networth | 10.64 % |
| Debt/Equity Ratio | 0.00 |
| Return on Equity | 5.00 % |
* Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
Directors - TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED
The company has 4 directors and 1 reported key management personnel.
The longest serving director currently on board is Gopal Agrawal who was appointed on 08 August, 2019. Gopal Agrawal has been on the board for 4 years and 8 months. The most recently appointed director is Serina Magner Fischer, who was appointed on 15 March, 2022.
Rajesh Eric Dmellokamath has the largest number of other directorships with a seat at a total of 4 companies. In total, the company is connected to 3 other companies through its directors.
| NAME | DESIGNATION | APPOINTMENT DATE | |
|---|---|---|---|
| GUNJAN MALHOTRA | KMP | 05 July, 2016 | No other directorships |
| GOPAL AGRAWAL | Director | 08 August, 2019 | View other directorships |
| ANOOP KISHORE KAMAT | Director | 23 April, 2021 | View other directorships |
| RAJESH ERIC DMELLOKAMATH | Director | 31 July, 2021 | View other directorships |
| SERINA MAGNER FISCHER | Director | 15 March, 2022 | View other directorships |
Previous Names
| BAXALTA BIOSCIENCE INDIA PRIVATE LIMITED |
Previous CINs
| No previous CINs were found for this company. |
SIMILAR COMPANIES
| NAME | INCORPORATION YEAR | STATE | PAID UP CAPITAL | |
|---|---|---|---|---|
|
TRENT HYPERMARKET PRIVATE LIMITED
It was formed in year 2008 in Maharashtra . The company currently has a paid up capital of INR 215.85 cr.
|
2008 | Maharashtra | 215.85 cr | Buy financial reports |
|
GLADIATOR VYAPAAR PVT.LTD.
It was formed in year 1995 in West Bengal . The company currently has a paid up capital of INR 221.84 cr.
|
1995 | West Bengal | 221.84 cr | Buy financial reports |
|
P C MEDIA SYSTEMS LIMITED
It was formed in year 1980 in Delhi . The company currently has a paid up capital of INR 206.00 cr.
|
1980 | Delhi | 206.00 cr | Buy financial reports |
|
FRESH & HEALTHY ENTERPRISES LIMITED
It was formed in year 2006 in Delhi . The company currently has a paid up capital of INR 226.03 cr.
|
2006 | Delhi | 226.03 cr | Buy financial reports |
|
SHIGA ENERGY PRIVATE LIMITED
It was formed in year 2005 in Delhi . The company currently has a paid up capital of INR 204.42 cr.
|
2005 | Delhi | 204.42 cr | Buy financial reports |
|
AVANCE TECHNOLOGIES LIMITED
It was formed in year 1985 in Maharashtra . The company currently has a paid up capital of INR 198.19 cr.
|
1985 | Maharashtra | 198.19 cr | Buy financial reports |
|
VICTORINOX INDIA PRIVATE LIMITED
It was formed in year 2006 in Maharashtra . The company currently has a paid up capital of INR 196.29 cr.
|
2006 | Maharashtra | 196.29 cr | Buy financial reports |
|
CIMMCO VINIMAY PVT LTD
It was formed in year 1994 in West Bengal . The company currently has a paid up capital of INR 235.53 cr.
|
1994 | West Bengal | 235.53 cr | Buy financial reports |
|
BRIGHT LIFECARE PRIVATE LIMITED
It was formed in year 2011 in Delhi . The company currently has a paid up capital of INR 238.51 cr.
|
2011 | Delhi | 238.51 cr | Buy financial reports |
|
MISUMI INDIA PRIVATE LIMITED
It was formed in year 2009 in Haryana . The company currently has a paid up capital of INR 187.87 cr.
|
2009 | Haryana | 187.87 cr | Buy financial reports |
SUBSIDIARY COMPANIES
No Indian subsidiary companies found.
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to their respective owners. Read More